Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2012 1
2013 3
2014 4
2015 5
2016 5
2017 5
2018 4
2019 5
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario.
Rossi G, Pezzuto A, Sini C, Tuzi A, Citarella F, McCusker MG, Nigro O, Tanda E, Russo A. Rossi G, et al. Among authors: sini c. Crit Rev Oncol Hematol. 2019 Oct;142:26-34. doi: 10.1016/j.critrevonc.2019.07.005. Epub 2019 Jul 22. Crit Rev Oncol Hematol. 2019. PMID: 31352168 Review.
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient.
Rossi G, Russo A, Tagliamento M, Tuzi A, Nigro O, Vallome G, Sini C, Grassi M, Dal Bello MG, Coco S, Longo L, Zullo L, Tanda ET, Dellepiane C, Pronzato P, Genova C. Rossi G, et al. Among authors: sini c. Cancers (Basel). 2020 Apr 30;12(5):1125. doi: 10.3390/cancers12051125. Cancers (Basel). 2020. PMID: 32365882 Free PMC article. Review.
Ct radiomic features of pancreatic neuroendocrine neoplasms (panNEN) are robust against delineation uncertainty.
Mori M, Benedetti G, Partelli S, Sini C, Andreasi V, Broggi S, Barbera M, Cattaneo GM, Muffatti F, Panzeri M, Falconi M, Fiorino C, De Cobelli F. Mori M, et al. Among authors: sini c. Phys Med. 2019 Jan;57:41-46. doi: 10.1016/j.ejmp.2018.12.005. Epub 2018 Dec 18. Phys Med. 2019. PMID: 30738530
Acquired resistance in oncogene-addicted non-small-cell lung cancer.
Sini C, Tuzi A, Rossi G, Russo A, Pezzuto A. Sini C, et al. Future Oncol. 2018 Jun;14(13s):29-40. doi: 10.2217/fon-2018-0097. Future Oncol. 2018. PMID: 29989451 Review.
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer.
Dinapoli N, Barbaro B, Gatta R, Chiloiro G, Casà C, Masciocchi C, Damiani A, Boldrini L, Gambacorta MA, Dezio M, Mattiucci GC, Balducci M, van Soest J, Dekker A, Lambin P, Fiorino C, Sini C, De Cobelli F, Di Muzio N, Gumina C, Passoni P, Manfredi R, Valentini V. Dinapoli N, et al. Among authors: sini c. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):765-774. doi: 10.1016/j.ijrobp.2018.04.065. Epub 2018 May 4. Int J Radiat Oncol Biol Phys. 2018. PMID: 29891200
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
Facchini G, Rossetti S, Berretta M, Cavaliere C, Scagliarini S, Vitale MG, Ciccarese C, Di Lorenzo G, Palesandro E, Conteduca V, Basso U, Naglieri E, Farnesi A, Aieta M, Borsellino N, La Torre L, Iovane G, Bonomi L, Gasparro D, Ricevuto E, De Tursi M, De Vivo R, Lo Re G, Grillone F, Marchetti P, De Vita F, Scavelli C, Sini C, Pisconti S, Crispo A, Gebbia V, Maestri A, Galli L, De Giorgi U, Iacovelli R, Buonerba C, Cartenì G, D'Aniello C. Facchini G, et al. Among authors: sini c. J Transl Med. 2019 Aug 29;17(1):296. doi: 10.1186/s12967-019-2047-4. J Transl Med. 2019. PMID: 31464635 Free PMC article.
Role of microRNAs in malignant mesothelioma.
Truini A, Coco S, Alama A, Genova C, Sini C, Dal Bello MG, Barletta G, Rijavec E, Burrafato G, Boccardo F, Grossi F. Truini A, et al. Among authors: sini c. Cell Mol Life Sci. 2014 Aug;71(15):2865-78. doi: 10.1007/s00018-014-1584-5. Epub 2014 Feb 23. Cell Mol Life Sci. 2014. PMID: 24562347 Review.
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.
Rijavec E, Genova C, Alama A, Barletta G, Sini C, Pronzato P, Coco S, Dal Bello MG, Savarino G, Truini A, Boccardo F, Grossi F. Rijavec E, et al. Among authors: sini c. Future Oncol. 2014 Jan;10(1):79-90. doi: 10.2217/fon.13.145. Future Oncol. 2014. PMID: 24328411 Review.
Oral vinorelbine in the treatment of non-small-cell lung cancer.
Barletta G, Genova C, Rijavec E, Burrafato G, Biello F, Sini C, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Beltramini S, Grassi MA, Boccardo F, Grossi F. Barletta G, et al. Among authors: sini c. Expert Opin Pharmacother. 2014 Aug;15(11):1585-99. doi: 10.1517/14656566.2014.934224. Epub 2014 Jun 27. Expert Opin Pharmacother. 2014. PMID: 24972635 Review.
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.
Passaro A, Prelaj A, Bonanno L, Tiseo M, Tuzi A, Proto C, Chiari R, Rocco D, Genova C, Sini C, Cortinovis D, Pilotto S, Landi L, Bennati C, Camerini A, Toschi L, Putzu C, Cerea G, Spitaleri G, Cappuzzo F, de Marinis F. Passaro A, et al. Among authors: sini c. Clin Lung Cancer. 2019 Mar;20(2):e186-e194. doi: 10.1016/j.cllc.2018.11.005. Epub 2018 Nov 20. Clin Lung Cancer. 2019. PMID: 30563752
29 results
Jump to page
Feedback